Original filing (PDF)20241025211444NAL0000426561001

Ankasa Regenerative Therapeutics,Inc.

Name: Ankasa Regenerative Therapeutics,Inc. — Ankasa Regen, Form 5500 (2023)
Creator: Ankasa Regenerative Therapeutics,Inc.
License: https://www.usa.gov/government-works

Form 5500-SF

FILING_RECEIVED

Ankasa Regenerative Therapeutics,Inc. 401(k) Plan

401(k) retirement plan · Ankasa Regenerative Therapeutics,Inc.'s Ankasa Regenerative Therapeutics,Inc. 401(k) Plan filed a Form 5500 for plan year 2023.

Active participants

Accounts w/ balance

Plan assets (EOY)

Net assets (EOY)

People on this filing

Katie Klink signed Ankasa Regenerative Therapeutics,Inc.'s 2023 Form 5500 as plan administrator.

Katie Klink — Plan Administrator — Form 5500 signer

Get verified email & phone for these signers

Signer names are public record from the Form 5500 e-signature.

Plan identifiers

Ankasa Regenerative Therapeutics,Inc.'s EIN is 47-1928158.

EIN 47-1928158

Plan number 001

Plan year 2023

ACK ID 20241025211444NAL0000426561001

Official Form 5500 document

Download the official 2023 Form 5500 (PDF) for Ankasa Regenerative Therapeutics,Inc. from the U.S. Department of Labor's EFAST2 system.

Download the official 2023 Form 5500 (PDF)

Plan features

Ankasa Regenerative Therapeutics,Inc.'s plan includes profit-sharing, ERISA 404(c) participant direction, a 401(k) feature, a default investment (QDIA).

Decision-maker contacts

One unlock reveals every key decision-maker — plan signer, CFO, HR & Benefits — with verified email + LinkedIn for ANKASA REGENERATIVE THERAPEUTICS,INC..

Finding similar companies…

Plan health score

Top-tier plan health

Directional indicator from public Form 5500 data — compliance & integrity, total plan cost, participant health and vendor stack, benchmarked against same-size peers. Not a fiduciary tool. Based on 50% of scoring inputs for this filing.

Compliance & integrity

100

Total plan cost

n/a

Plan health

n/a

Vendor & structure

100

Helping the score